Please assess the completion status of the following clinical trial:

Trial Title: Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Part1:Inclusion Criteria:~* • Healthy pregnant women of any age~  * Two or more previous C-sections~ * Gestational age between 38-40 weeks (confirmed by dating scan)~ * Dense Adhesions of Tulandi scores four or more.~ * women who give informed consent to participate in the study~Exclusion Criteria~:• Patients with medical disorders~* Bladder injury before group assignment~* Placenta previa~* Subjects experiencing micturition problems (dysuria, frequency, urgency, urinary retention, incontinence) before the study.~Eligibility criteria of part 2\&3 will be provided after publication -

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Cystoinflation group (Type: EXPERIMENTAL): Bladder will be recognized by observing its gradual distension during bladder retro-fill with 300cc saline to perform adhesiolysis.
- Control group (Type: NO_INTERVENTION): Pelvic adhesiolysis will be performed without bladder retrofill.

Based on this trial design, predict the completion outcome and termination type (if applicable).